Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane in infants with congenital heart disease
NCT03366597Unknown
- Start
- Jan 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sevoflurane in congenital heart disease (CHD). Primary endpoint: Concentration of S100β protein. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
congenital heart disease (CHD)
Beyond the preview
Go deeper on NCT03366597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03366597.